Abstract
Prosthetic graft occlusion is most frequent in the early postoperative period when the luminal surface is highly thrombogenic. It is generally believed that graft maturation ultimately results in a non-thrombogenic surface. The accumulation of 111-indium-labelled autologous platelets in Dacron aortofemoral grafts has been measured 1 week following surgery and at intervals of 6 months to 1 year.
Platelets from 9 patients were labelled with 111-indium oxine and re-injected. Isotope emissions over the graft and a reference site (aortic arch) were measured daily for 8 days and gamma camera images taken on alternate days. Graft thrombogenicity was calculated as the daily rise in the graft: reference ratio of emissions.
All grafts, regardless of age, accumulated platelets and were imaged by gamma camera. Mean thrombogenicity (± s.e.mean) 1 week after surgery was 0·21 ± 0·04 compared with 0·08 ± 0·03 at follow-up (P < 0·01). The platelet survival during the early study was reduced at 6·8 ± 0·6 days but recovered to a value of 8·6 ± 0·8 days (P < 0·01) at follow-up. Further grafts, 2, 5 and 9 years old, were studied and all accumulated platelets, especially near the anastomoses.
Platelet accumulation on Dacron grafts does diminish with time but persists beyond the period of altered platelet survival and perhaps indefinitely.
Contributor Information
M Goldman, Department of Surgery, Queen Elizabeth Medical Centre, Birmingham B15 2TH; Department of Nuclear Medicine, Queen Elizabeth Medical Centre, Birmingham B15 2TH.
H C Norcott, Department of Surgery, Queen Elizabeth Medical Centre, Birmingham B15 2TH; Department of Nuclear Medicine, Queen Elizabeth Medical Centre, Birmingham B15 2TH.
R J Hawker, Department of Surgery, Queen Elizabeth Medical Centre, Birmingham B15 2TH; Department of Nuclear Medicine, Queen Elizabeth Medical Centre, Birmingham B15 2TH.
Z Drolc, Department of Surgery, Queen Elizabeth Medical Centre, Birmingham B15 2TH; Department of Nuclear Medicine, Queen Elizabeth Medical Centre, Birmingham B15 2TH.
C N McCollum, Department of Surgery, Queen Elizabeth Medical Centre, Birmingham B15 2TH; Department of Nuclear Medicine, Queen Elizabeth Medical Centre, Birmingham B15 2TH.
References
- 1. Hamlin G W, Rajah S M, Crow M J et al. : Evaluation of the thrombogenic potential of three types of arterial graft studied in an artificial circulation. Br. J. Surg. 1978; 65: 272–6. [DOI] [PubMed] [Google Scholar]
- 2. Goldman M, Norcott H C, Hawker R J et al. : Femoro popliteal bypass grafts: an isotope technique allowing in vivo comparison of thrombogenicity. Br. J. Surg. 1982; 69: in the press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Harker L A, Slichter S J and Sauvage L R: Platelet consumption by arterial prostheses: the effects of endothelialisation and pharmacologic inhibition of platelet function. Ann. Surg. 1977; 186: 594–601. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. McCollum C N, Kester R, Rajah S M et al. : Arterial graft maturation: the duration of thrombotic activity in Dacron aortobifemoral grafts measured by platelet and fibrinogen kinetics. Br. J. Surg. 1981; 68: 61–4. [PubMed] [Google Scholar]
- 5. Hawker R J, Hawker L M and Wilkinson A R: Indium (111-In) labelled human platelets: optimal method. Clin. Sci. 1980; 58: 243–8. [DOI] [PubMed] [Google Scholar]
- 6. Ross R, Glomset J, Kariya B et al. : A platelet dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Natl Acad. Sci. USA 1974; 71: 1207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Oblath R W, Buckley F O, Green R M et al. : Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole. Surgery 1978; 84: 37–44. [PubMed] [Google Scholar]